Showing results (201-210 of 369) with videos related to

Sort By:
Pageof 37
The Lancet. Oncology|March 28, 2024
Cost and value of cancer medicines in a single-payer public health system in Ontario, Canada: a cross-sectional studyJoseph C Del Paggio, Rohini Naipaul, Scott Gavura, et al.
JCO Clinical Cancer Informatics|January 7, 2021
Chemotherapy Knowledge Base Management in the Era of Precision OncologySamuel M Rubinstein, Tarsheen Sethi, Neeta K Venepalli, et al.
Future Oncology (London, England)|June 7, 2023
Comparison of tumor-agnostic and tumor-specific clinical oncology trial designs: a systematic review and meta-analysisMufiza Farid-Kapadia, Madelyn Barton, Zoe Bider-Canfield, et al.
JCO Global Oncology|November 13, 2025
Availability, Affordability, and Variations in Price of GI Cancer Medicines in NepalRamila Shilpakar, Brian Shkabari, Bibek Acharya, et al.
Journal of Medical Internet Research|August 25, 2022
The Impact of Artificial Intelligence on Health Equity in Oncology: Scoping ReviewPaul Istasy, Wen Shen Lee, Alla Iansavichene, et al.
Journal of Thoracic Disease|January 22, 2024
Development and validation of a DNA damage repair-related gene-based prediction model for the prognosis of lung adenocarcinomaChu Qin, Xiaodong Fan, Xiaoyan Sai, et al.
Oncology Reviews|August 13, 2020
Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigmGiuseppe Luigi Banna, Ornella Cantale, Melissa Bersanelli, et al.
Ecancermedicalscience|November 26, 2021
Healthcare delivery for non-communicable diseases among breast cancer survivors in Sri Lanka: Is there a missed opportunity?Don Thiwanka Wijeratne, Christopher M Booth, Sanjeewa Seneviratne, et al.
Current Oncology (Toronto, Ont.)|April 30, 2021
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled TrialsShubham Sharma, J Connor Wells, Wilma M Hopman, et al.
Pageof 37